Long-term data with idebenone on respiratory function outcomes in patients with Duchenne muscular dystrophy
Decline in respiratory function in patients with DMD starts during early teenage years and leads to early morbidity and mortality. Published evidence of efficacy for idebenone on respiratory function outcomes is currently limited to 12 months of follow-up time. Here we report data collected as retro...
Główni autorzy: | Servais, L, Straathof, CSM, Schara, U, Klein, A, Leinonen, M, Hasham, S, Meier, T, De Waele, L, Gordish-Dressman, H, McDonald, CM, Mayer, OH, Voit, T, Mercuri, E, Buyse, GM |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
Elsevier
2019
|
Podobne zapisy
-
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
od: Fatima Amor, i wsp.
Wydane: (2021-06-01) -
Duchenne Muscular Dystrophy
od: J Gordon Millichap
Wydane: (1989-05-01) -
Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
od: Frank, DE, i wsp.
Wydane: (2020) -
Muscular Fatigue in Duchenne Dystrophy
od: J Gordon Millichap
Wydane: (1995-02-01) -
Glucocorticoids for Duchenne Muscular Dystrophy
od: J Gordon Millichap
Wydane: (2013-07-01)